American Research Journal of Biotechnology       cover
Open Access

American Research Journal of Biotechnology

ISSN (Online):

DOI: 10.46568/arjbt

Research Article Vol. 1, Issue 1 2025 Open Access

Multidrug-Resistant Bacteria are no Match for Silver Nanoparticles, a Potent Nanoweapon

Luo Da, Den Hui 

Department of Biotechnology, University of Johannesburg, Johannesburg, South Africa. 
Citation: Luo Da, Den Hui, “ Multidrug-Resistant Bacteria are no Match for Silver Nanoparticles, a Potent Nanoweapon”, American Research Journal of Biotechnology, Vol 1, no. 1, 2022, pp. 7-14
Abstract

Resistance to various drugs has become a growing problem for pharmaceutical and biomedical businesses (MDR). infectious microbes When germs become resistant to antibiotics or are able to reproduce in unfavorable environments, they are more likely to reappear. Multidrug-resistant illnesses need expensive, long-term treatment in addition to increasing mortality and morbidity. Antimicrobial agents must be created, modified, or discovered as a result of this. An significant research goal is to identify MDR-killing compounds. Silver has been used in various compounds and bhasmas for thousands of years. It has been used in Ayurveda for a long time as a bactericide. The use of silver nanoparticles may help combat antibiotic-resistant microorganisms. It has been shown that silver nanoparticles can kill MDR bacteria. A system that can be put to a variety of different uses. Patients who are no longer able to take their current prescriptions may benefit from nanotechnology-based drugs. microbes.